Fibrosis mechanisms and updates in potential therapeutic targets in systemic sclerosis

Area of Science:

• Immunology and Rheumatology
• Fibrosis Research
• Autoimmune Diseases

Background:

• Systemic sclerosis (SSc) is a rare autoimmune disease affecting multiple organs.
• Characterized by microvascular issues, inflammation, and progressive fibrosis.
• Current treatment options for SSc, particularly fibrosis, are limited.

Purpose of the Study:

• To review emerging therapeutic strategies for Systemic Sclerosis (SSc).
• To focus on novel targets in fibrosis pathways.
• To highlight potential improvements in patient outcomes.

Main Methods:

• Literature review of recent clinical trials and research.
• Analysis of emerging therapeutic targets.
• Discussion of SSc pathogenesis and fibrosis mechanisms.

Main Results:

• Significant progress has been made in targeting key fibrotic pathways.
• Several novel therapeutic targets show promise for SSc treatment.
• Combination therapies may enhance patient outcomes.

Conclusions:

• Emerging strategies targeting TGF-β signaling, OSM receptor β, and others offer new hope for SSc.
• Further research and clinical trials are crucial to validate these approaches.
• Targeting fibrosis pathways holds potential to significantly improve SSc patient care.